Thierry Alcindor, MD

Harvard University,, Dana-Farber Cancer Center
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• Paper 34 - A PHASE II STUDY OF DURVALUMAB AND TREMELIMUMAB IN PATIENTS WITH ADVANCED OSTEOSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA

  Friday, November 3, 2023
  9:00 AM – 10:00 AM  

• Session 10: Trials in Progress

  Saturday, November 4, 2023
  9:00 AM – 10:00 AM